Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Breast cancer, female
Trial Type:  Prevention
Trial Status:  Active
Results 1-25 of 28 for your search:
Start Over
Multi-centre Clinical Trial on Hormone Replacement Treatment in China
Phase: Phase IV
Type: Prevention
Status: Active
Age: 40-to 60
Sponsor: Other
Protocol IDs: 2008BAI57B04, NCT01698164
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
Phase: Phase III
Type: Prevention
Status: Active
Age: 30 to 75
Sponsor: Other
Protocol IDs: GD-10-08, NCT00808522
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: GAL 01, NCT01357772
Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Approved-not yet active
Age: 25 to 55
Sponsor: NCI, Other
Protocol IDs: A211102, U10CA031946, NCI-2013-00995, NCT01905046
Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 200806, NCT01425476
Changes in Biomarkers Using Prostaglandin Inhibitors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 200807-001, NCT01769625
Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
Phase: Phase II
Type: Prevention
Status: Active
Age: 30 to 90
Sponsor: Other
Protocol IDs: 102/07 (HT4351), NCT00496288
Statins and Breast Cancer Biomarkers
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 35 to 55
Sponsor: Other
Protocol IDs: V0407, CHRMS#: 05-059, NCT00914017
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 25 and over
Sponsor: NCI, Other
Protocol IDs: 08218, R01CA140245-01, NCI-2010-01976, NCT01196936
Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 to 49
Sponsor: Other
Protocol IDs: 12377, NCT01276704
Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-0794, NCI-2012-00037, KG09 1020, NCT01471106
Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia
Phase: Phase II
Type: Prevention
Status: Active
Age: Not Specified
Sponsor: Other
Protocol IDs: Institut Jules Bordet, NCT01658956
NSAID Effects on Clinical and Imaging Breast Biomarkers
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 75 and under
Sponsor: Other
Protocol IDs: 1RO1 CA1615301A1, 12-0080-04, NCT01761877
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00859, 12-474, 12-267, N01-CN-2012-00034, AAAK6752, MSKCC-12-267, H-33017, 2011-0766, MDA10-16-01, N01CN00034, N01CN35159, P30CA016672, NCT01849250
BRCA1/2 and Effect of Mifepristone on the Breast
Phase: Phase II
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-003703-35, NCT01898312
Acute Exercise Cardioprotection From Doxorubicin
Phase: Phase II
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H13-03090, NCT02006979
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
Phase: Phase II
Type: Prevention
Status: Active
Age: 30 to 45
Sponsor: NCI, Other
Protocol IDs: 1300000596, 1R01CA172444-01A1, NCT02028221
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 45 to 70
Sponsor: Other
Protocol IDs: STUDY00000703, NCT02101970
Breast Cancer - Anti-Progestin Prevention Study 1
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 25 to 45
Sponsor: Other
Protocol IDs: UHSM0315, NCT02408770
The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 25 to 45
Sponsor: Other
Protocol IDs: 2009-015-B, NCT01022333
Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
Phase: No phase specified
Type: Prevention
Status: Active
Age: 18 to 35
Sponsor: Other
Protocol IDs: HS-10-00455, NCT01318005
Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 30 to 55
Sponsor: Other
Protocol IDs: PSHCI 12-075, NCT01784042
Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: IUCRO-0365, NCI-2013-00422, NCT01793948
Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
Phase: No phase specified
Type: Prevention
Status: Active
Age: 19 and over
Sponsor: Other
Protocol IDs: OSU-13034, NCI-2013-01199, NCT01975363
Olive Oil for Breast Cancer Prevention in Women at High Risk for Breast Cancer
Phase: No phase specified
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0713-0108, Pro00009472, NCT02068092
Start Over